IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Apimeds Pharmaceuticals US I (APUS)

CUSIP: 03771D102 | NYSE | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 18 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AApimeds Inc.
with Inscobee Inc.
4,316,61834.3%UnchangedMay 7, 2026No 13F filer matched
13D/AApimeds Inc.4,316,618

Institutional Holders — Q2 2026

Hemenway Trust Co LLC274,000
0.0% of portfolio›$246.6K
Vanguard Capital Management LLC63,654
0.0% of portfolio›$57.3K
Geode Capital Management, LLC35,114
0.0% of portfolio›$31.6K
Vanguard Fiduciary Trust Co24,039
0.0% of portfolio›$21.6K
Jane Street Group, LLC15,993
0.0% of portfolio›$14.4K
UBS Group AG11,818
0.0% of portfolio›$10.6K
Tower Research Capital LLC (TRC)1,664
0.0% of portfolio›$1.5K
StyleTurnoverLocationFiled
Hemenway Trust Co LLC
274,000$246.6K0.0%GrowthLowSalem, NH2026-08-11
Vanguard Capital Management LLC
63,654$57.3K0.0%CoreN/AMalvern, PA2026-08-13
Geode Capital Management, LLC
35,114$31.6K0.0%IndexVery LowBoston, MA2026-08-12
Vanguard Fiduciary Trust Co
24,039$21.6K0.0%CoreN/AMalvern, PA2026-08-13
Jane Street Group, LLC
15,993$14.4K0.0%CoreVery HighNew York, NY2026-08-14
UBS Group AG
11,818$10.6K0.0%CoreMediumZurich, Switzerland2026-08-13
Tower Research Capital LLC (TRC)
1,664$1.5K0.0%GARPVery HighNew York, NY2026-08-11
34.3% of class · May 7, 2026
Unchanged
with Inscobee Inc.
No 13F filer matched